Announcement
02 Apr 2020
In April 2020, Advanced Development and Manufacturing (CIADM) at Emergent Biosolutions is allocated USD 14 million for the development of a plasma-based therapeutic treatment for COVID-19.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
02 Apr 2020
Revocation date:
No revocation date
Updated: 02 Apr 2020
State aid, unspecified
In force
On 2 April 2020, Biomedical Advanced Research and Development Authority (BARDA) announced providing USD 14 million funding for the development of a plasma-based therapeutic treatment for COVID-19. ...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.